Randomised multicentre trial on safety and efficacy of rivastigmine in cognitively impaired multiple sclerosis patients. Mäurer M, Ortler S, Baier M, Meergans M, Scherer P, Hofmann W, Tracik F Mult Scler. 2012 Oct 15. PMID: 23069874. Abstract CommentRecommendBookmarkWatch